Drug Design, London, UK
Event Feb 28
The conference aims to cover key areas such as: the advances in high-throughput docking, overcoming protein flexibility in modelling, ADME/TOX predictive methods, new algorithms for design, reducing the drug candidate attrition rate, Novel Protein Kinase Inhibitors: SMART drug design technologies, scaffolds, new advances in structure-based drug design (SBDD) including protein flexibility into docking schemes, free energy calculation: perturbation methods, empirical scoring functions, virtual screening, active site prediction and modelling.
2nd Annual Artificial Intelligence in Drug Development Congress
Sep 20 - Sep 21, 2018